Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Nicola Blackwood, the MP for Oxford West and Abingdon, spent the day in Nuffield Department of Surgical Sciences with Professor Kathryn Wood and her research group, Transplantation Research Immunology Group (TRIG) last Friday, 17th January 2014. This was a reciprocal visit arranged through the Royal Society’s MP- Scientist pairing scheme which aims to build bridges between parliamentarians and some of the best scientists in the UK.

The aim of the visit was to demonstrate how translational research is taken from “bench to bedside”, and how discoveries made in the lab can eventually impact the treatments that patients receive.

During the day, Nicola met with Kathryn and the group and had the opportunity to discuss the group’s portfolio of research and see some of the different techniques used in the lab such as how stem cells are grown, and how cells are sorted and imaged.  Nicola also visited the Oxford Transplant Centre where she met Professor Peter Friend and some of the staff and patients.

2014-01-24 Pairing SchemeAt the end of the day, Nicola tweeted:   “Just spent an amazing day with Prof Wood's transplant & Immunology team at JR …”   

Image: from left to right: Kathryn Wood, Nicola Blackwood, Liz Wallin 

Link: 

Nuffield Department of Surgical Sciences  

Transplantation Research Immunology Group

Nicola Blackwood

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.